Issued Patents All Time
Showing 1–25 of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12403182 | Liquid pharmaceutical formulations of PTH conjugates | Anja R. H. Skands, Felix Cleemann, Michael Duelund Sørensen, Julia Baron, Eric Hoffmann | 2025-09-02 |
| 12303553 | Long-acting growth hormone dosage forms with superior efficacy to daily somatropin | — | 2025-05-20 |
| 12295989 | Controlled-release PTH compound | Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler, Lars Holten-Andersen +1 more | 2025-05-13 |
| 12274737 | PEGylated recombinant human growth hormone compounds | Harald Rau, Susanne Kindermann, Torben Leßmann, Grethe Norskov Rasmussen, Ulrich Hersel +1 more | 2025-04-15 |
| 12239689 | Controlled-release CNP agonists with low initial NPR-B activity | Harald Rau, Felix Cleemann, Ulrich Hersel | 2025-03-04 |
| 12214020 | PTH prodrugs | Felix Cleemann, Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler | 2025-02-04 |
| 12156917 | CNP prodrugs with carrier attachment at the ring moiety | Harald Rau, Ulrich Hersel, Felix Cleemann | 2024-12-03 |
| 12083182 | Controlled-release CNP agonists with increased NEP stability | Harald Rau, Ulrich Hersel, Felix Cleemann | 2024-09-10 |
| 12016903 | Long-acting growth hormone treatment | Henrik Egesborg, Steen Jensen, Thomas Kurpiers | 2024-06-25 |
| 11918628 | Controlled-release PTH compound | Felix Cleemann, Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler | 2024-03-05 |
| 11890326 | Controlled-release PTH compound | Felix Cleemann, Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler | 2024-02-06 |
| 11857603 | PTH compounds with low peak-to-trough ratios | Lars Holten-Andersen, David Karpf, Felix Cleemann, Guillaume Maitro, Mathias Krusch +2 more | 2024-01-02 |
| 11793861 | PTH prodrugs | Felix Cleemann, Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler | 2023-10-24 |
| 11759504 | PTH compounds with low peak-to-trough ratios | Lars Holten-Andersen, David Karpf, Felix Cleemann, Guillaume Maitro, Mathias Krusch +2 more | 2023-09-19 |
| 11590207 | Dosage regimen for a controlled-release PTH compound | Lars Holten-Andersen, David Karpf | 2023-02-28 |
| 11564974 | Combination therapy with controlled-release CNP agonists | Lars Holten-Andersen, Vibeke Miller Breinholt | 2023-01-31 |
| 11389511 | Controlled-release CNP agonists with reduced side-effects | Harald Rau, Felix Cleemann, Ulrich Hersel, Caroline Elisabeth Rasmussen | 2022-07-19 |
| 11389510 | Controlled-release CNP agonists with low initial NPR-B activity | Harald Rau, Felix Cleemann, Ulrich Hersel, Caroline Elisabeth Rasmussen | 2022-07-19 |
| 11311604 | Controlled-release CNP agonists with low NPR-C binding | Harald Rau, Ulrich Hersel, Frank Faltinger, Thomas Wegge, Felix Cleemann | 2022-04-26 |
| 11224661 | Controlled-release CNP agonists with increased NEP stability | Harald Rau, Ana Bernhard, Ulrich Hersel, Felix Cleenmann, Thomas Wegge | 2022-01-18 |
| 10980860 | Diagnosis, prevention and treatment of diseases of the joint | Dirk Vetter, Ulrich Hersel, Nora Kaluza, Oliver Keil, Guillaume Maitro +1 more | 2021-04-20 |
| 10960053 | PEGylated recombinant human growth hormone compounds | Harald Rau, Susanne Kindermann, Torben Leßmann, Grethe Norskov Rasmussen, Ulrich Hersel +1 more | 2021-03-30 |
| 10729778 | Carrier-linked treprostinil prodrugs | Ulrich Hersel, Harald Rau, Torben Lessmann, Nicola Bisek, Guillaume Maitro +3 more | 2020-08-04 |
| 10519226 | VEGF neutralizing prodrugs for the treatment of ocular conditions | Harald Rau, Thomas Knappe, Burkhardt Laufer, Romy Reimann, Samuel Weisbrod +3 more | 2019-12-31 |
| 9872864 | Sustained release composition of prostacyclin | Harald Rau, Ulrich Hersel, Thomas Wegge, Oliver Keil, Joachim Zettler | 2018-01-23 |